MIRA Pharmaceuticals Inc. (MIRA)
MIRA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.6664
-5.53% on the day
Market cap
$28.0M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MIRA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2023 |
| SEC CIK | 0001904286 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | FL |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-05 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-17 |
| Latest proxy | DEF 14A | 2026-07-28 |
Source: SEC EDGAR submissions feed, 196 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RNAZ | TransCode Therapeutics Inc. | $1.68 | +3.07% | $28.4M |
| IGC | IGC Pharma Inc. | $0.2650 | -3.99% | $27.4M |
| NXTC | NextCure Inc. | $6.28 | -5.42% | $28.7M |
| IMMP | Immutep Limited | $3.57 | -2.73% | $26.3M |
| ABVC | ABVC BioPharma Inc. | $0.9790 | -0.08% | $26.1M |
| ATOS | Atossa Therapeutics Inc. | $2.56 | +7.17% | $25.5M |
| MCRB | Seres Therapeutics Inc. | $2.53 | -5.60% | $25.4M |
| CNTX | Context Therapeutics Inc. | $0.2750 | -9.84% | $25.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier